Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Events>This Event
  Events - December 2012


Early Drug Development Summit 2012

03 Dec 2012 - 04 Dec 2012 - Berlin, Germany



Bookmark and Share


The Early Drug Development Summit is taking place on 3rd-4th December 2012 at the Hotel Palace Berlin, Germany. 

This leading industry summit brings early drug developers together to discuss maximising drug investments, toxicology, safety and biomarkers.  

How should companies address strategies and tools to fully optimise their drug development trajectory to bringing safe, effective and commercially viable drugs to market faster whilst achieving regulatory approval? 

•         Andreas Schneider, Vice President Life Science Alliances, Roche - 

Maximising drug investments by effectively managing early drug development pipelines through the use of knowledge management.

•         Dr Khusru Asadullah, Vice President, Head of Global Biomarker, Bayer HealthCare 

Obtaining grants for biomarkers – setting up open innovation in drug development between industry and academia

•         Amer Alghbban, Director Global Quality Auditing, Merck Serono

Overcoming stringent regulatory barriers – accelerating drug approvals by meeting the requirements of ICH S4

Find out more at www.eddsummit.com 

Save £300 on your registration when booking on www.eddsummit.com/offer 

For further information or to book your place email Michaela Melcher, michaela.melcher@wtgevents.com or call +44(0)20 7202 7690



Further information
Scientific News
The Changing Tides of the In Vitro Diagnostics Market
With the increasing focus in personalized medicine, diagnostics plays a crucial role in patient monitoring.
LaVision BioTec Reports on the Neuro Research on the Human Brain After Trauma
Company reports on the work of Dr Ali Ertürk from the Institute for Stroke and Dementia Research at LMU Munich.
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
Less May Be More in Slowing Cholera Epidemics
Mathematical model shows more cases may be prevented and more lives saved when using one dose of cholera vaccine instead of recommended two doses.
Investigating the Vape
Expert independent review concludes that e-cigarettes have potential to help smokers quit.
NIH Launches Human RSV Study
Study aims to understand infection in healthy adults to aid development of RSV medicines, vaccines.
Researchers Discover Synthesis of a New Nanomaterial
Interdisciplinary team creates biocomposite for first time using physiological conditions.
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
Flu Remedies Help Combat E. coli Bacteria
Physiologists from the University of Zurich have now discovered why the intestinal bacterium Escherichia coli (E. coli) multiplies heavily and has an inflammatory effect.
Marijuana Genome Unraveled
A study by Canadian researchers is providing a clearer picture of the evolutionary history and genetic organization of cannabis, a step that could have agricultural, medical and legal implications for this valuable crop.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!